Within3 is Committed to Providing the Most Relevant Information in the Industry

2016 Industry Trends In Online Discussion Meetings

October 26, 2016 | White Paper

It seems as if all things are online now – shopping, education, entertainment – it was only a matter of time before the life sciences industry followed suit. Life science companies are constantly tasked with engaging healthcare professionals in order to help with all aspects of a drug lifecycle. The advent of online discussion platforms has allowed companies to engage with these stakeholders more frequently and at lower costs.

Read More

Improving Speakers Bureau Communications

May 05, 2016 | White Paper

Modern technology has the ability to improve speakers bureau programs. At a high level, speakers bureau software can reduce costs and expertly organize and schedule dinner meetings, creating a strong foundation for effective and valuable programs. However, the challenges with existing programs has not allowed for the highest quality materials to be presented by the best educated speakers to the most extensive audiences.

The following white paper identifies three crucial communication challenges within a speakers bureau program and how to address them. 
Read More

505(b)(2) Drug Development Pathway

February 19, 2016 | White Paper

The 505(b)(2) regulatory pathway is one of three categories of new drug applications (NDA). While the application requires full safety and effectiveness reports, it gives the FDA permission to use data not gathered by the NDA applicant, avoiding unnecessary duplicate analyses. Employing a 505(b)(2) regulatory strategy can offer significant benefits, encouraging innovation while offering a faster, more cost-efficient way to drug development. 
Read More

Top 3 Impacts of Patient-Centered Care in Marketing

February 11, 2016 | White Paper

The Institute of Medicine (IOM) defines patient-centered care as, “Providing care that is respectful of and responsive to individual patient preferences, needs and values, and ensuring that patient values guide all clinical decisions.” Practicing patient-centered care improves patient outcomes while cultivating the quality of doctor-patient relationships.How can this translate to the marketing of pharmaceuticals?
Read More

Top 5 Pharma Stories of 2015

January 15, 2016 | White Paper

2015 was a wild ride for the pharma industry. We saw high profile mergers, landmark developments and, yes, damaging criticisms. These events, for better or for worse, are likely to shape the pharma landscape for 2016. Here are the top stories that consistently found their way into the headlines.
Read More